237 related articles for article (PubMed ID: 20709739)
1. Podoplanin-positive cells are a hallmark of encapsulating peritoneal sclerosis.
Braun N; Alscher DM; Fritz P; Edenhofer I; Kimmel M; Gaspert A; Reimold F; Bode-Lesniewska B; Ziegler U; Biegger D; Wüthrich RP; Segerer S
Nephrol Dial Transplant; 2011 Mar; 26(3):1033-41. PubMed ID: 20709739
[TBL] [Abstract][Full Text] [Related]
2. Encapsulating peritoneal sclerosis--a complication of peritoneal dialysis.
Chembo C; Macdonald A; Hay N; Matheson P; Pidgeon G; Leikis M
N Z Med J; 2011 Sep; 124(1342):89-93. PubMed ID: 21963929
[TBL] [Abstract][Full Text] [Related]
3. The spectrum of podoplanin expression in encapsulating peritoneal sclerosis.
Braun N; Alscher MD; Fritz P; Latus J; Edenhofer I; Reimold F; Alper SL; Kimmel M; Biegger D; Lindenmeyer M; Cohen CD; Wüthrich RP; Segerer S
PLoS One; 2012; 7(12):e53382. PubMed ID: 23300922
[TBL] [Abstract][Full Text] [Related]
4. Encapsulating peritoneal sclerosis in children on chronic PD: a survey from the European Paediatric Dialysis Working Group.
Shroff R; Stefanidis CJ; Askiti V; Edefonti A; Testa S; Ekim M; Kavaz A; Ariceta G; Bakkaloglu S; Fischbach M; Klaus G; Zurowska A; Holtta T; Jankauskiene A; Vondrak K; Vande Walle J; Schmitt CP; Watson AR;
Nephrol Dial Transplant; 2013 Jul; 28(7):1908-14. PubMed ID: 23348882
[TBL] [Abstract][Full Text] [Related]
5. Encapsulating peritoneal sclerosis: what have we learned?
Goodlad C; Brown EA
Semin Nephrol; 2011 Mar; 31(2):183-98. PubMed ID: 21439432
[TBL] [Abstract][Full Text] [Related]
6. Management of encapsulating peritoneal sclerosis: a guideline on optimal and uniform treatment.
Habib SM; Betjes MG; Fieren MW; Boeschoten EW; Abrahams AC; Boer WH; Struijk DG; Ruger W; Krikke C; Westerhuis R; de Sévaux RG; van der Sande FM; Gaasbeek A; Korte MR;
Neth J Med; 2011; 69(11):500-7. PubMed ID: 22173363
[TBL] [Abstract][Full Text] [Related]
7. [Peritoneal dialysis: a time-limited therapy because of encapsulating peritoneal sclerosis?].
Bertoli SV; Musetti C
G Ital Nefrol; 2010; 27(5):464-8. PubMed ID: 20922677
[TBL] [Abstract][Full Text] [Related]
8. Tamoxifen is associated with lower mortality of encapsulating peritoneal sclerosis: results of the Dutch Multicentre EPS Study.
Korte MR; Fieren MW; Sampimon DE; Lingsma HF; Weimar W; Betjes MG;
Nephrol Dial Transplant; 2011 Feb; 26(2):691-7. PubMed ID: 20584735
[TBL] [Abstract][Full Text] [Related]
9. Encapsulating peritoneal sclerosis.
Cisse MM; Dia D; Seck SM; Cisse M; Ka EF; Gueye S; Tall AO; Niang A; Diouf B
Saudi J Kidney Dis Transpl; 2013 Nov; 24(6):1203-6. PubMed ID: 24231485
[TBL] [Abstract][Full Text] [Related]
10. Additive effectiveness of everolimus plus tamoxifen therapy in treatment of encapsulating peritoneal sclerosis.
Huddam B; Azak A; Koçak G; Başaran M; Voyvoda N; Duranay M
Ren Fail; 2012; 34(3):387-9. PubMed ID: 22263915
[TBL] [Abstract][Full Text] [Related]
11. Development of encapsulating peritoneal sclerosis following bacterial peritonitis in a peritoneal dialysis patient.
Hsu YH; Hsia CC; Tsai DM; Tu HY; Hung KY; Huang JW
Am J Kidney Dis; 2010 Jan; 55(1):198-202. PubMed ID: 19782452
[No Abstract] [Full Text] [Related]
12. CD147 expression in peritoneal injury.
Seeger H; Latus J; Kitterer D; Alscher MD; Biegger D; Chen J; Edenhofer I; Wüthrich RP; Segerer S
Clin Exp Nephrol; 2017 Dec; 21(6):1097-1104. PubMed ID: 28551820
[TBL] [Abstract][Full Text] [Related]
13. Risk factors for encapsulating peritoneal sclerosis in long-term peritoneal dialysis: a retrospective observational study.
Nakao M; Yokoyama K; Yamamoto I; Matsuo N; Tanno Y; Ohkido I; Hayakawa H; Ikeda M; Yamamoto H; Hosoya T
Ther Apher Dial; 2014 Feb; 18(1):68-73. PubMed ID: 24499086
[TBL] [Abstract][Full Text] [Related]
14. Encapsulating peritoneal sclerosis in patients on peritoneal dialysis.
Hendriks MP; de Sévaux RG; Hilbrands LB
Neth J Med; 2008; 66(7):269-74. PubMed ID: 18663253
[TBL] [Abstract][Full Text] [Related]
15. The time course of peritoneal transport parameters in peritoneal dialysis patients who develop encapsulating peritoneal sclerosis.
Sampimon DE; Coester AM; Struijk DG; Krediet RT
Nephrol Dial Transplant; 2011 Jan; 26(1):291-8. PubMed ID: 20566569
[TBL] [Abstract][Full Text] [Related]
16. Peritoneal effluent MMP-2 and PAI-1 in encapsulating peritoneal sclerosis.
Lopes Barreto D; Struijk DG; Krediet RT
Am J Kidney Dis; 2015 May; 65(5):748-53. PubMed ID: 25530106
[TBL] [Abstract][Full Text] [Related]
17. Encapsulating peritoneal sclerosis: common or rare in peritoneal dialysis?
Triga K
Saudi J Kidney Dis Transpl; 2013 Mar; 24(2):223-9. PubMed ID: 23538342
[TBL] [Abstract][Full Text] [Related]
18. [A case of encapsulating of peritoneal sclerosis with fast and ominous evolution].
Li Cavoli G; Tralongo A; Arena N; Scaturro B; Carollo F; Li Cavoli TV; Tralongo P; Rotolo U
G Ital Nefrol; 2016; 33(2):. PubMed ID: 27067218
[TBL] [Abstract][Full Text] [Related]
19. Seventeen years' experience of surgical options for encapsulating peritoneal sclerosis.
Kawanishi H; Shintaku S; Moriishi M; Dohi K; Tsuchiya S
Adv Perit Dial; 2011; 27():53-8. PubMed ID: 22073830
[TBL] [Abstract][Full Text] [Related]
20. Encapsulating peritoneal sclerosis: importance to the hemodialysis practitioner.
Perl J; Bargman JM; Chan CT
Hemodial Int; 2009 Oct; 13(4):446-52. PubMed ID: 19840139
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
